IP Library Assignment 042743/0001
Patent Assignment
Reel/Frame 042743/0001

Security Interest

Recorded: 2017-06-08 Pages: 31
Assignor
Assignee
WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL TRUSTEE
1100 NORTH MARKET STREET, WILMINGTON, DELAWARE, 19890
Covered Properties (32)
Sulfonic Acid and Aldehyde Condensation Polymers for Preventing Pregnancy
Patent: 5,958,399 →
Application: 08/847,019 →
Methods and Compositions for Alleviating Stuttering
Patent: 6,855,721 →
Application: 09/628,803 →
Hydrogel compositions useful for the sustained release of macromolecules and methods of making same
Patent: 6,361,797 →
Application: 09/646,066 →
Methods of Treating Obsessive-Compulsive Disorder
Patent: 7,026,332 →
Application: 10/133,471 →
Publication: US 2003/0022915
Methods for Identifying Compounds Capable of Supplementing the Biological Activity of Leptin
Patent: 6,953,670 →
Application: 10/245,616 →
Publication: US 2003/0082612
Methods for Making 2-(7-Chloro-1,8-Naphthyridine-2-Yl)-3-(5-Methyl-2-Oxo-Hexyl)-1-Isoindolinone
Patent: 6,949,653 →
Application: 10/400,780 →
Publication: US 2003/0191315
Implanting Device and Method of Using Same
Patent: 7,214,206 →
Application: 10/406,397 →
Publication: US 2004/0199140
Methods and Compositions for Alleviating Stuttering
Patent: 7,858,638 →
Application: 11/046,706 →
Publication: US 2005/0256029
Compositions and Methods for Treating Precocious Puberty
Patent: 8,062,652 →
Application: 11/155,822 →
Publication: US 2006/0019903
Methods for Making 2-(7-Chloro-1,8-Naphthyridine-2-Yl)-3-(5-Methyl-2OXO-Hexyl)-1-Isoidolinone
Patent: 7,057,047 →
Application: 11/206,144 →
Publication: US 2005/0288322
Use of Pagoclone for the Treatment of Social Anxiety Disorder
Patent: 7,553,847 →
Application: 11/352,286 →
Publication: US 2006/0128746
Controlled Release Formulations of Octreotide
Patent: 7,452,868 →
Application: 11/372,749 →
Publication: US 2006/0204540
Method for Making 2-(7-Chloro-1,8-Naphthyridine-2-Yl)-3-(5-Methyl-2-Oxo-Hexyl)-1-Isoindolinone)
Patent: 7,304,158 →
Application: 11/411,952 →
Publication: US 2006/0194830
Method of Inserting an Object Under the Skin
Patent: 7,510,549 →
Application: 11/531,311 →
Publication: US 2007/0073265
Implant Device Release Agents and Methods of Using Same
Patent: 9,120,249 →
Application: 12/109,852 →
Publication: US 2008/0311170
Delivery of Dry Formulations of Octreotide
Patent: 7,759,312 →
Application: 12/171,999 →
Publication: US 2009/0035343
Controlled Release Formulations of Octreotide
Patent: 7,803,773 →
Application: 12/240,690 →
Publication: US 2009/0087470
Sulfonic Acid and Aldehyde Condensation Polymers for the Treatment and Prevention of Hpv
Patent: 8,604,086 →
Application: 12/393,778 →
Publication: US 2009/0247639
Combination Treatment for Bladder Cancer
Patent: 8,273,721 →
Application: 12/397,831 →
Publication: US 2009/0227529
Implantation Device for Subcutaneous Implatation of an Object Under the Skin
Patent: 7,850,639 →
Application: 12/415,681 →
Publication: US 2009/0247939
An Implantable Device for the Sustained Release of a Polypeptide
Patent: 8,071,537 →
Application: 12/490,971 →
Publication: US 2010/0021522
Octreotide Implant Having a Release Agent and Uses Thereof
Patent: 7,960,335 →
Application: 12/490,979 →
Publication: US 2010/0022450
Controlled Release Formulations of Octreotide
Patent: 8,507,432 →
Application: 12/814,293 →
Publication: US 2010/0317579
A Method of Manufacturing an Implantable Device
Patent: 8,475,820 →
Application: 12/844,357 →
Publication: US 2010/0292144
Methods and Compositions for Alleviating Stuttering
Patent: 8,242,132 →
Application: 12/973,515 →
Publication: US 2011/0184012
Octreotide Implant Having a Release Agent
Patent: 8,383,577 →
Application: 13/098,138 →
Publication: US 2011/0206745
Methods and Compositions for Alleviating Stuttering
Patent: 8,618,127 →
Application: 13/489,516 →
Publication: US 2012/0245118
Method of Manufacturing an Implantable Device
Patent: 9,072,786 →
Application: 13/897,895 →
Publication: US 2013/0252894
Implantable Device for the Delivery of Octreotide and Methods of Use Thereof
Application: 14/534,415 →
Publication: US 2015/0283201
Delivery of Dry Formulations of Octreotide
Application: 15/246,009 →
Publication: US 2017/0049850
Controlled Release Formulations of Octreotide
Application: 15/246,020 →
Publication: US 2017/0100461
Implanting Device
Patent: 492,995 →
Application: 29/179,382 →
Related Assignments (19)
Other recorded transfers of the patents in this record — the chain of ownership.
Change of Name Feb 27, 2014
From: PROCEPT, INC.
To: HEAVENLYDOOR.COM, INC.
Reel/Frame 032366/0915 →
Merger and Change of Name Feb 27, 2014
From: HEAVENLYDOOR.COM, INC.
To: PALIGENT INC.
Reel/Frame 032366/0904 →
Release of Patent Security Interest Mar 3, 2014
From: MORGAN STANLEY SENIOR FUNDING, INC., AS ADMINISTRATIVE AGENT
To: ENDO PHARMACEUTICALS SOLUTIONS INC.
Reel/Frame 032380/0226 →
Grant of Security Interest in Patents Mar 20, 2014
From: ENDO PHARMACEUTICALS SOLUTIONS, INC.; ENDO PHARMACEUTICALS, INC.; AMS RESEARCH CORPORATION; AMERICAN MEDICAL SYSTEMS, INC.
To: DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT
Reel/Frame 032491/0440 →
Release of Security Interest Apr 28, 2017
From: DEUTSCHE BANK AG NEW YORK BRANCH
To: ENDO PHARMACEUTICALS, INC.; ENDO PHARMACEUTICALS SOLUTIONS, INC.; ASTORA WOMEN'S HEALTH HOLDINGS, LLC
Reel/Frame 042362/0001 →
Confirmatory Grant of Security Interest in United States Patents Apr 6, 2021
From: BIOSPECIFICS TECHNOLOGIES LLC; PAR PHARMACEUTICAL, INC.; AUXILIUM US HOLDINGS, LLC; ASTORA WOMEN'S HEALTH, LLC
To: WILMINGTON TRUST, NATIONAL ASSOCIATION
Reel/Frame 055845/0618 →
Confirmatory Grant of Security Interest in United States Patents Apr 6, 2021
From: BIOSPECIFICS TECHNOLOGIES LLC; PAR PHARMACEUTICAL, INC.; AUXILIUM US HOLDINGS, LLC; ASTORA WOMEN'S HEALTH, LLC
To: WILMINGTON TRUST, NATIONAL ASSOCIATION
Reel/Frame 055846/0246 →
Confirmatory Grant of Security Interest in United States Patents Sep 17, 2021
From: ASTORA WOMEN'S HEALTH LLC; ENDO PHARMACEUTICALS SOLUTIONS INC.; ENDO PHARMACEUTICALS INC.; PAR PHARMACEUTICAL, INC.
To: WILMINGTON TRUST, NATIONAL ASSOCIATION
Reel/Frame 057538/0978 →
Assignment of Assignor's Interest Apr 23, 2024
From: ENDO PHARMACEUTICALS SOLUTIONS INC.
To: ENDO USA, INC.
Reel/Frame 067198/0892 →
Release of Security Interest Apr 25, 2024
From: WILMINGTON TRUST, NATIONAL ASSOCIATION
To: ACTIENT PHARMACEUTICALS LLC; ASTORA WOMEN’S HEALTH LLC; AUXILIUM PHARMACEUTICALS, LLC; AUXILIUM US HOLDINGS, LLC
Reel/Frame 067239/0491 →
Release of Security Interest Apr 25, 2024
From: WILMINGTON TRUST, NATIONAL ASSOCIATION
To: ACTIENT PHARMACEUTICALS LLC; ASTORA WOMEN’S HEALTH LLC; AUXILIUM PHARMACEUTICALS, LLC; AUXILIUM US HOLDINGS, LLC
Reel/Frame 067239/0542 →
Release of Security Interest Apr 26, 2024
From: WILMINGTON TRUST, NATIONAL ASSOCIATION
To: ACTIENT PHARMACEUTICALS LLC; ASTORA WOMEN’S HEALTH HOLDINGS, LLC; ASTORA WOMEN’S HEALTH LLC; AUXILIUM PHARMACEUTICALS, LLC
Reel/Frame 067240/0001 →
Release of Security Interest Apr 26, 2024
From: WILMINGTON TRUST, NATIONAL ASSOCIATION
To: ACTIENT PHARMACEUTICALS LLC; ASTORA WOMEN’S HEALTH HOLDINGS, LLC; ASTORA WOMEN’S HEALTH LLC; AUXILIUM PHARMACEUTICALS, LLC
Reel/Frame 067239/0795 →
Assignment of Assignor's Interest Apr 27, 2024
From: ENDO USA, INC.
To: ENDO OPERATIONS LIMITED
Reel/Frame 067245/0492 →
Assignment of Assignor's Interest Jun 21, 2024
From: ENDO USA, INC.
To: ENDO OPERATIONS LIMITED
Reel/Frame 067800/0107 →
Security Interest Jul 19, 2024
From: ENDO BIOLOGICS LIMITED; ENDO OPERATIONS LIMITED
To: GOLDMAN SACHS BANK USA
Reel/Frame 068461/0692 →
Security Interest Jul 22, 2024
From: ENDO BIOLOGICS LIMITED; ENDO OPERATIONS LIMITED
To: COMPUTERSHARE TRUST COMPANY, NATIONAL ASSOCIATION
Reel/Frame 068469/0001 →
Security Interest Aug 26, 2024
From: ENDO OPERATIONS LIMITED
To: COMPUTERSHARE TRUST COMPANY, NATIONAL ASSOCIATION
Reel/Frame 068401/0390 →
Security Interest Aug 26, 2024
From: ENDO OPERATIONS LIMITED
To: GOLDMAN SACHS BANK USA
Reel/Frame 068401/0578 →